- Home
- TDW vs SLNO Comparison
TDW vs SLNO Comparison
Compare TDW & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TDW | SLNO |
|---|---|---|
| Founded | 1956 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | TDW | SLNO |
|---|---|---|
| Price | $57.67 | $51.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $67.50 | ★ $110.90 |
| AVG Volume (30 Days) | 936.3K | ★ 1.8M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.97 | N/A |
| Revenue | ★ $1,361,073,000.00 | $98,675,000.00 |
| Revenue This Year | $0.76 | N/A |
| Revenue Next Year | $0.81 | $155.86 |
| P/E Ratio | $19.42 | ★ N/A |
| Revenue Growth | ★ 4.42 | N/A |
| 52 Week Low | $31.17 | $41.50 |
| 52 Week High | $64.07 | $90.32 |
Technical Indicators
Market Signals| Indicator | TDW | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 57.12 | 48.33 |
| Support Level | $53.38 | $47.80 |
| Resistance Level | $55.36 | $53.10 |
| Average True Range (ATR) | 2.83 | 2.47 |
| MACD | 0.38 | 1.09 |
| Stochastic Oscillator | 73.19 | 79.48 |
Price Performance
Historical ComparisonAbout TDW Tidewater Inc.
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.